Implanet S.A. (ALIMP.PA)
- Previous Close
0.1000 - Open
0.1016 - Bid --
- Ask --
- Day's Range
0.1000 - 0.1016 - 52 Week Range
0.0812 - 0.1675 - Volume
400 - Avg. Volume
79,121 - Market Cap (intraday)
12.497M - Beta (5Y Monthly) 0.96
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Implanet S.A., a medical technology company, manufactures and sells implants and instrument for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products. Its products include Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Jazz Frame, and ISS-Jazz Screw systems for posterior fixation. It also provides ultrasonic osteotomy surgical system; and knee prostheses under the Madison name. Implanet S.A.was founded in 2006 and is based in Martillac, France.
www.implanet.comRecent News: ALIMP.PA
View MorePerformance Overview: ALIMP.PA
Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALIMP.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALIMP.PA
View MoreValuation Measures
Market Cap
12.50M
Enterprise Value
17.07M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.24
Price/Book (mrq)
17.19
Enterprise Value/Revenue
1.81
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-46.42%
Return on Assets (ttm)
-23.64%
Return on Equity (ttm)
-1,886.44%
Revenue (ttm)
9.41M
Net Income Avi to Common (ttm)
-5.22M
Diluted EPS (ttm)
-0.0400
Balance Sheet and Cash Flow
Total Cash (mrq)
1.6M
Total Debt/Equity (mrq)
848.83%
Levered Free Cash Flow (ttm)
-1.73M